Detalhe da pesquisa
1.
A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.
Am J Hematol
; 93(7): 867-873, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658143
2.
New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.
Hemasphere
; 8(4): e70, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650598